2nd Quarter - Report

BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION

Firm
Client
Income
—
Expenses
$420,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Transpacific Partnership (TPP) - Supporting passage for greater regulatory harmonization across Asia-Pacific country members and to include transparency and procedural fairness provisions in the agreement. Transatlantic Trade & Investment Partnership (T-TIP) - Supporting passage for greater regulatory harmonization of product approvals and registration

LobbyistCovered position, as disclosed
PAUL E BARRY —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Comprehensive/Corporate Tax Reform W&M Discussion Draft - Includes lower corporate tax rate, research credit transition, and base erosion Senate Finance Tax Reform Discussion Draft - International Tax Reform Provisions - Tax Extender Provisions

LobbyistCovered position, as disclosed
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

H.R. 3326 Defend Trade Secrets Act - legislation to establish a Federal Civil cause of action for Trade Secret Misappropriation S. 1890 - Defend Trade Secrets Act - legislation to establish a Federal Civil cause of action for Trade Secret Misappropriation

LobbyistCovered position, as disclosed
PAUL E BARRY —
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1890 (114th), H.R. 3326 (114th)

Health Issues HCR

Public Law 112-144 - Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) specifically pertaining to user fees used to train FDA staff and streamline approval process Unique Device Identifiers (UDI) - Implementation of UDI rule H.R. 6 - 21st Century Cures Initiative - Legislation to accelerate the pace of biomedical innovation and cures by modernizing federal research and regulatory agencies Innovation for Healthier Americans (Senate, companion) - Legislation to accelerate the pace of biomedical innovation and cures by modernizing federal research and regulatory agencies FDA/CMS Breakthrough Pathway - H.R. 5009 - Legislation to harmonize CMS Reimbursement with FDA Approval to speed products' market introduction S. 524 - H.R. 943 - Comprehensive Addiction & Recovery Act (CARA) - Bill to address the National Opioid epidemic. Specifically, Advocacy for FDA approved alternative treatments for Chronic Pain H.R. 4641 - Pain Best Practices

LobbyistCovered position, as disclosed
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), S. 524 (114th), H.R. 943 (114th), H.R. 4641 (114th), H.R. 5009 (114th)

Veterans VET

VHA Directive 2009-053 - Pain care directive - working to increase veteran access to pain specialists and FDA approved alternative treatments in the VHA. Public Law No 113-146 - Veterans Access, Choice, and Accountability Act: Implementation of law to allow veterans to seek healthcare from non-VA facilities if unable to receive care from the VA in a timely manner. VA Vendor Credentialing - Proposals to establish a national credentialing system for VA National Pain Strategy - Encouraging adaption of the NIH's National Pain Strategy H.R. 4063 - S. 1641 - Promise Act - Legislation to improve quality of Pain Care provided

LobbyistCovered position, as disclosed
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1641 (114th), H.R. 4063 (114th)

Budget/Appropriations BUD

Public Law No 113-6 - CONSOLIDATED AND FURTHER CONTINUING APPROPRIATIONS ACT, 2013 - Specifically, have been working on relief of 5% sequestration of FDA CDRH User Fees Public Law No: 113-67 - Making continuing appropriations for fiscal year 2014, and for other purposes. Specifically provisions providing appropriations for the FDAs CDRH evaluation of medical technology. FY 2016 Agriculture Appropriations Bill (House) - FDA Funding FY 2016 Agriculture Appropriations Bill (Senate) - FDA Funding

LobbyistCovered position, as disclosed
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Transportation TRA

H.R. 4441 - Aviation Innovation, Reform and Re-authorization Act of 2016 - Limitations on aircraft transportation of lithium batteries S. 2658 - Federal Aviation Administration Re-authorization Act of 2016 - Limitations on aircraft transportation of lithium batteries H.R. 636 - FAA Extension - Limitations on aircraft transportation of lithium batteries

LobbyistCovered position, as disclosed
BRENDA BECKER —
ISAAC A FORDJOUR —
STEVEN NEIL LAPIERRE —
CHRISTOPHER LEE TIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4441 (114th), S. 2658 (114th), H.R. 636 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.